This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
PICO
Question: Among adolescents and young adults 17–21 years old, what proportion meet criteria for pharmacologic treatment of elevated low-density lipoprotein cholesterol under pediatric versus adult dyslipidemia guidelines?
Question type: Descriptive
Study design: Cross-sectional survey
Investigators from multiple institutions analyzed data from the National Health and Nutrition Examination Survey (NHANES) to estimate the proportion of 17- to 21-year-olds who meet criteria for pharmacologic treatment of elevated low-density lipoprotein cholesterol (LDL-C) dyslipidemia with statins under current pediatric and adult dyslipidemia guidelines. The 2011 National Heart, Lung, and Blood Institute pediatric guidelines recommend universal screening for 17- to 21-year-olds and statin treatment for those with LDL-C ≥190 mg/dL without other risk factors or ≥130 mg/dL if other risk factors are …
Individual Login
Institutional Login
You may be able to gain access using your login credentials for your institution. Contact your librarian or administrator if you do not have a username and password.
Log in through your institution
Pay Per Article - You may access this article (from the computer you are currently using) for 2 days for US$25.00
Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.
In this issue
Jump to section
Related Articles
Cited By...
- No citing articles found.